Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1996 Feb;34(2):277–281. doi: 10.1128/jcm.34.2.277-281.1996

Analysis of HL and O serotypes of Campylobacter strains by the flagellin gene typing system.

I Nachamkin 1, H Ung 1, C M Patton 1
PMCID: PMC228782  PMID: 8789000

Abstract

We recently developed a molecular typing system for Campylobacter jejuni and Campylobacter coli based on restriction fragment length polymorphism analysis of the flagellin gene,flaA (I.Nachamkin, K. Bohachick, and C.M. Patton, J. Clin. Microbiol. 31:1531-1536, 1993). We extended the typing system to 83 flagellin types (designated flaA-1,flaA-2, etc.) on the basis of analysis of 404 isolates of C. jejuni and C. coli including common serotypes isolated in the United States, a selection of less common serotypes, and serotype reference strains. Of the 295 strains previously shown to belong to common HL and O serotypes (C. M. Patton, M.A. Nicholson, S.M. Ostroff, A.A. Ries, I.K. Wachsmuth, and R.V. Tauxe, J. Clin. Microbiol. 31:1525-1530, 1993), six flaA types accounted for 53.6% of strains as follows: flaA-1, 21.7%; flaA-7, 14.9%; flaA-27, 5.1%; flaA-49, 4.4%; flaA-13, 3.7%; and flaA-21, 3.7%. Seventy-five percent of the strains were within 15 flaA types, 90% were within 30 flaA types, and all 295 strains were contained within 52 flaA types. Within each HL or O serotype, there usually were multiple flaA types. For 12 common HL serotypes and 7 common O serotypes, more than 50% of these isolates were a single flaA type. A database was developed by using commercially available restriction fragment length polymorphism analysis software (ProRFLP; DNA ProScan, Inc., Nashville, Tenn.) that should allow other investigators to perform typing with this system.

Full Text

The Full Text of this article is available as a PDF (176.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aeschbacher M., Piffaretti J. C. Population genetics of human and animal enteric Campylobacter strains. Infect Immun. 1989 May;57(5):1432–1437. doi: 10.1128/iai.57.5.1432-1437.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aspinall G. O., Fujimoto S., McDonald A. G., Pang H., Kurjanczyk L. A., Penner J. L. Lipopolysaccharides from Campylobacter jejuni associated with Guillain-Barré syndrome patients mimic human gangliosides in structure. Infect Immun. 1994 May;62(5):2122–2125. doi: 10.1128/iai.62.5.2122-2125.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cowden J. Campylobacter: epidemiological paradoxes. BMJ. 1992 Jul 18;305(6846):132–133. doi: 10.1136/bmj.305.6846.132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Lior H., Woodward D. L., Edgar J. A., Laroche L. J., Gill P. Serotyping of Campylobacter jejuni by slide agglutination based on heat-labile antigenic factors. J Clin Microbiol. 1982 May;15(5):761–768. doi: 10.1128/jcm.15.5.761-768.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Mishu B., Blaser M. J. Role of infection due to Campylobacter jejuni in the initiation of Guillain-Barré syndrome. Clin Infect Dis. 1993 Jul;17(1):104–108. doi: 10.1093/clinids/17.1.104. [DOI] [PubMed] [Google Scholar]
  6. Mishu B., Ilyas A. A., Koski C. L., Vriesendorp F., Cook S. D., Mithen F. A., Blaser M. J. Serologic evidence of previous Campylobacter jejuni infection in patients with the Guillain-Barré syndrome. Ann Intern Med. 1993 Jun 15;118(12):947–953. doi: 10.7326/0003-4819-118-12-199306150-00006. [DOI] [PubMed] [Google Scholar]
  7. Nachamkin I., Bohachick K., Patton C. M. Flagellin gene typing of Campylobacter jejuni by restriction fragment length polymorphism analysis. J Clin Microbiol. 1993 Jun;31(6):1531–1536. doi: 10.1128/jcm.31.6.1531-1536.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Patton C. M., Nicholson M. A., Ostroff S. M., Ries A. A., Wachsmuth I. K., Tauxe R. V. Common somatic O and heat-labile serotypes among Campylobacter strains from sporadic infections in the United States. J Clin Microbiol. 1993 Jun;31(6):1525–1530. doi: 10.1128/jcm.31.6.1525-1530.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Patton C. M., Wachsmuth I. K., Evins G. M., Kiehlbauch J. A., Plikaytis B. D., Troup N., Tompkins L., Lior H. Evaluation of 10 methods to distinguish epidemic-associated Campylobacter strains. J Clin Microbiol. 1991 Apr;29(4):680–688. doi: 10.1128/jcm.29.4.680-688.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Penner J. L., Hennessy J. N. Passive hemagglutination technique for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigens. J Clin Microbiol. 1980 Dec;12(6):732–737. doi: 10.1128/jcm.12.6.732-737.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Yuki N., Taki T., Inagaki F., Kasama T., Takahashi M., Saito K., Handa S., Miyatake T. A bacterium lipopolysaccharide that elicits Guillain-Barré syndrome has a GM1 ganglioside-like structure. J Exp Med. 1993 Nov 1;178(5):1771–1775. doi: 10.1084/jem.178.5.1771. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES